An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Conditions:   SARS-CoV-2 Infection;   COVID-19;   Moderate and Severe COVID-19 Interventions:   Other: Standard of Care (SoC);   Drug: Remdesivir Sponsors:   Professor Dr. Bernd Mühlbauer;   Dept. of Statistics and Medical Biometry, University of Bremen;   INSERM (Institut national de la santé et de la recherche médicale), Paris, France;   World Health Organization (WHO), R&D Blueprint, Geneva, Switzerland Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials